(VIANEWS) – Shares of FibroGen (NASDAQ: FGEN) rose 5.07% to $14.08 at 10:54 EST on Thursday, after two sequential sessions in a row of losses. NASDAQ is rising 1.4% to $14,540.72, after two successive sessions in a row of losses. This seems, up until now, an all-around bullish trend exchanging session today.
FibroGen’s last close was $13.40, 76.58% below its 52-week high of $57.21.
Today’s last reported volume for FibroGen is 99423 which is 91.32% below its average volume of 1146738.
FibroGen’s sales growth is 201.9% for the present quarter and 13.3% for the next. The company’s growth estimates for the ongoing quarter is a negative 134.3% and positive 39.1% for the next.
Year-on-year quarterly revenue growth declined by 43.2%, now sitting on 171.82M for the twelve trailing months.
FibroGen’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.52%, a positive 0.47%, and a positive 2.76%, respectively.
FibroGen’s highest amplitude of average volatility was 3.14% (last week), 2.77% (last month), and 2.76% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
FibroGen’s stock is considered to be overbought (>=80).
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $14.08 at 10:54 EST, way below its 52-week high of $57.21 and way higher than its 52-week low of $9.88.
FibroGen’s Moving Average
FibroGen’s value is way higher than its 50-day moving average of $11.90 and way below its 200-day moving average of $18.77.
More news about FibroGen (FGEN).